PDS Biotechnology Corporation Common Stock (PDSB)
Across 21 earnings reports since Aug 12, 2021, PDS Biotechnology Corporation Common Stock (PDSB) has a clear post-earnings pattern. It moves ±8.21% on average after reporting and finishes higher 52.4% of the time. Its largest post-earnings gain was +25.4% (Nov 14, 2022) and its largest decline was -18.59% (Nov 14, 2024). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How PDSB moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±8.21%
Positive %
52.4%
Negative %
47.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☀ PRE | -1.25% | open_in_new |
| May 13, 2026 | ☀ PRE | +19.64% | open_in_new |
| Mar 30, 2026 | ☀ PRE | +2.04% | open_in_new |
| Nov 13, 2025 | ☀ PRE | -12.32% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±8.21%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260908 | open_in_new SEC.gov |
| 8-K | 20260904 | open_in_new SEC.gov |
| 8-K | 20260825 | open_in_new SEC.gov |
| 8-K | 20260819 | open_in_new SEC.gov |
| 8-K | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
| 8-K | 20260811 | open_in_new SEC.gov |
| 8-K | 20260731 | open_in_new SEC.gov |
| 424B4 | 20260721 | open_in_new SEC.gov |
Frequently asked about PDSB earnings
When does PDS Biotechnology Corporation Common Stock report earnings next? expand_more
PDS Biotechnology Corporation Common Stock (PDSB)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does PDSB stock move after earnings? expand_more
Over 21 reports, PDSB has moved an average of ±8.21% the session after earnings, closing higher 52.4% of the time.
What was PDSB's biggest post-earnings move? expand_more
PDSB's largest post-earnings gain on record was +25.4% on Nov 14, 2022, and its largest decline was -18.59% on Nov 14, 2024.
Where can I find PDS Biotechnology Corporation Common Stock's SEC filings? expand_more
All of PDS Biotechnology Corporation Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right